NUCLEUS SOFTWARE EXPORTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 ,inter alia, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company would be held on Thursday, the 11th August 2022 for the following purpose: a) For Approval and Adoption of Audited Standalone financial results of the Company for the Quarter ended June 30, 2022; b) For Approval and Adoption of Unaudited Consolidated financial results of the Company for the Quarter ended June 30, 2022; The financial results duly approved by the Board of Directors shall be declared at the conclusion of the Board Meeting on 11th August 2022.

With reference to the above mentioned subject, Please find the enclosed herewith Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June 2022.

With reference to the above mentioned subject, Please find the enclosed herewith Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June 2022.

In terms of the Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Press Release duly issued by the Company announcing that Nucleus Software's FinnOne Neo to transform PVcom Bank's retail lending.

This is with reference to the above referred letter. We would like to confirm that the Company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, from time to time. We have not withheld any material information/event that in our opinion would have a bearing on the price/volume behavior in our scrip. The spurt in volume of our scrip is purely market driven. The Company has been sharing all information/announcements that may have a bearing on the price/volume behavior of the scrip and is strictly following all the listing norms of disclosures under applicable Regulations.

This is with reference to the above referred letter. We would like to confirm that the Company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, from time to time. We have not withheld any material information/event that in our opinion would have a bearing on the price/volume behavior in our scrip. The spurt in volume of our scrip is purely market driven. The Company has been sharing all information/announcements that may have a bearing on the price/volume behavior of the scrip and is strictly following all the listing norms of disclosures under applicable Regulations.

The Exchange has sought clarification from Nucleus Software Exports Ltd on July 11, 2022, with reference to Movement in Volume.The reply is awaited.

Nucleus Software Exports Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

With reference to the above mentioned subject, please find enclosed herewith copy of voting results of Annual General Meeting (AGM) held on 08th July 2022 in respect of business transacted in the notice of AGM as per Regulation 44 of SEBI (LODR) Regulation 2015. The Report of the Scrutinizer pursuant to Section 110 of the Companies Act, 2013 and Rule 22(13) of the Companies (Management and Administration) Rules, 2014 is also enclosed herewith for your reference. The same shall also be available on the website of the Company i.e. www.nucleussoftware.com.

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0770 Name of the Signatory :- Poonam BhasinDesignation :- Company Secretary and Compliance Officer